Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 33 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07020117
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
- Locations
-
- City of Hope Duarte, California, United States
- Hoag Memorial Hospital Presbyterian Irvine, California, United States
- Biogenix Molecular, LLC Miami, Florida, United States
- Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States
NCT05312671
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Johns Hopkins University: Sibley Memorial Hospital Washington D.C., District of Columbia, United States
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
Recruiting
Intervention of Bladder Cancer by CAR-T
NCT03185468
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
NCT06184516
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- University of Florida Gainesville, Florida, United States
NCT06586255
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT06806059
- Conditions
- Behavior, Motor Activity, Urothelial Carcinoma Bladder
- Locations
-
- Department of Urology, LMU Hospital Munich, Bavaria, Germany
NCT05483868
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Arkansas Urology Little Rock, Arkansas, United States
- Tower Urology Los Angeles, California, United States
- Saint John's Cancer Institute Santa Monica, California, United States
- Montefiore Medical Center The Bronx, New York, United States
NCT06444815
- Conditions
- Adenocarcinoma, Adenoma, Bronchial Neoplasms, +56 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health Orange, California, United States
- University of Miami Miami, Florida, United States
- Community Health Network Indianapolis, Indiana, United States
NCT05037279
- Conditions
- Bladder Cancer, Bladder Cancer Recurrent, Disease Attributes, +18 more
- Locations
-
- Site 05 Vancouver, British Columbia, Canada
- Site 04 Kingston, Ontario, Canada
- Site 01 Toronto, Ontario, Canada
- Site 02 Toronto, Ontario, Canada
Recruiting
Bladder EpiCheck European Haematuria Study
NCT06818136
- Conditions
- Cystoscopy, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- NHS Fife Dunfermline, Fife, United Kingdom
- Addenbrooke's Hospital Cambridge, United Kingdom
- NHS Lothian Edinburgh, United Kingdom
- Guy's and St Thomas London, United Kingdom
NCT05656235
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Johns Hopkins University: Sibley Memorial Hospital Washington D.C., District of Columbia, United States
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
NCT06983210
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +20 more
- Locations
-
- Nagoya University Hospital Nagoya, Aichi-ken, Japan
Recruiting
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
NCT06823427
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +6 more
- Locations
-
- Hunan Tumor Hospital Changsha, Hunan, China
- Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
Enrolling by Invitation
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
NCT07218003
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
- Locations
-
- UCSF Medical Center San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- START Midwest Grand Rapids, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Not Yet Recruiting
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
NCT07725796
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +20 more
- Locations
-
- East Valley Urology Center of Arizona Queen Creek, Arizona, United States
- Michael G Oefelein Clinical Trials Bakersfield, California, United States
- Urology Center of Southern California Murrieta, California, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
Not Yet Recruiting
Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial
NCT07555769
- Conditions
- Bladder Tumor, Bladder Tumors, Carcinoma, +16 more
- Locations
-
Not specified
Not Yet Recruiting
A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer
NCT07464145
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Carcinoma, +17 more
- Locations
-
Not specified
Not Yet Recruiting
A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.
NCT07064863
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +16 more
- Locations
-
- Kingston Health Sciences Center Kingston, Ontario, Canada
Not Yet Recruiting
JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival Outcomes
NCT06901934
- Conditions
- Urothelial Carcinoma Bladder
- Locations
-
Not specified
Completed
Phase Ib of L-NMMA and Pembrolizumab
NCT03236935
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +30 more
- Locations
-
- Houston Methodist Cancer Center Houston, Texas, United States